Latest Insider Transactions at Clover Health Investments, Corp. (CLOV)
This section provides a real-time view of insider transactions for Clover Health Investments, Corp. (CLOV). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of CLOVER HEALTH INVESTMENTS, CORP. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of CLOVER HEALTH INVESTMENTS, CORP. 's insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Mar 14
2023
|
Joseph Richards Martin General Counsel |
SELL
Payment of exercise price or tax liability
|
Direct |
283,091
-9.13%
|
$0
$0.93 P/Share
|
|
Mar 14
2023
|
Jamie L. Reynoso CEO, Medicare Advantage |
SELL
Payment of exercise price or tax liability
|
Direct |
31,455
-2.22%
|
$0
$0.93 P/Share
|
|
Jan 31
2023
|
Jamie L. Reynoso CEO, Medicare Advantage |
SELL
Payment of exercise price or tax liability
|
Direct |
1,281
-0.09%
|
$1,281
$1.33 P/Share
|
|
Jan 07
2023
|
Vivek Garipalli Director |
SELL
Payment of exercise price or tax liability
|
Direct |
1,569,594
-100.0%
|
$1,569,594
$1.01 P/Share
|
|
Jan 07
2023
|
Vivek Garipalli Director |
BUY
Exercise of conversion of derivative security
|
Direct |
1,569,594
+50.0%
|
-
|
|
Jan 07
2023
|
Jamie L. Reynoso CEO, Medicare Advantage |
SELL
Payment of exercise price or tax liability
|
Direct |
16,369
-1.14%
|
$16,369
$1.01 P/Share
|
|
Jan 03
2023
|
Anna U Loengard Director |
BUY
Grant, award, or other acquisition
|
Direct |
176,991
+47.5%
|
-
|
|
Jan 03
2023
|
Chelsea Clinton Director |
BUY
Grant, award, or other acquisition
|
Direct |
176,991
+34.53%
|
-
|
|
Jan 03
2023
|
Carladenise Armbrister Edwards Director |
BUY
Grant, award, or other acquisition
|
Direct |
176,991
+46.2%
|
-
|
|
Jan 03
2023
|
Demetrios L. Kouzoukas Director |
BUY
Grant, award, or other acquisition
|
Direct |
176,991
+44.26%
|
-
|
|
Jan 03
2023
|
Lee Shapiro Director |
BUY
Grant, award, or other acquisition
|
Direct |
176,991
+34.81%
|
-
|
|
Jan 03
2023
|
William G Robinson Jr Director |
BUY
Grant, award, or other acquisition
|
Direct |
176,991
+41.31%
|
-
|
|
Jan 03
2023
|
Jamie L. Reynoso CEO, Medicare Advantage |
BUY
Grant, award, or other acquisition
|
Direct |
353,982
+19.57%
|
-
|
|
Jan 01
2023
|
Andrew Toy Chief Executive Officer |
BUY
Grant, award, or other acquisition
|
Direct |
9,734,513
+43.92%
|
-
|
|
Nov 28
2022
|
Anna U Loengard Director |
BUY
Grant, award, or other acquisition
|
Direct |
12,665
+50.0%
|
-
|
|
Sep 22
2022
|
Chelsea Clinton Director |
BUY
Grant, award, or other acquisition
|
Direct |
20,271
+11.33%
|
-
|
|
Sep 22
2022
|
Chelsea Clinton Director |
BUY
Exercise of conversion of derivative security
|
Direct |
38,392
+21.72%
|
-
|
|
Sep 22
2022
|
William G Robinson Jr Director |
BUY
Grant, award, or other acquisition
|
Direct |
20,271
+21.4%
|
-
|
|
Sep 22
2022
|
William G Robinson Jr Director |
BUY
Exercise of conversion of derivative security
|
Direct |
27,100
+33.33%
|
-
|
|
Sep 22
2022
|
Carladenise Armbrister Edwards Director |
BUY
Grant, award, or other acquisition
|
Direct |
20,271
+41.08%
|
-
|
|
Sep 22
2022
|
Demetrios L. Kouzoukas Director |
BUY
Grant, award, or other acquisition
|
Direct |
20,271
+30.64%
|
-
|
|
Sep 22
2022
|
Demetrios L. Kouzoukas Director |
BUY
Exercise of conversion of derivative security
|
Direct |
25,608
+50.0%
|
-
|
|
Sep 22
2022
|
Lee Shapiro Director |
BUY
Grant, award, or other acquisition
|
Direct |
20,271
+11.6%
|
-
|
|
Sep 22
2022
|
Lee Shapiro Director |
BUY
Exercise of conversion of derivative security
|
Direct |
27,100
+16.8%
|
-
|
|
Sep 16
2022
|
Jamie L. Reynoso CEO, Medicare Advantage |
BUY
Grant, award, or other acquisition
|
Direct |
353,356
+24.3%
|
-
|
|
Sep 16
2022
|
Prabhdeep Singh Chief Growth Officer |
BUY
Grant, award, or other acquisition
|
Direct |
353,356
+28.82%
|
-
|
|
Aug 08
2022
|
Andrew Toy Chief Executive Officer |
BUY
Grant, award, or other acquisition
|
Direct |
2,695,072
+50.0%
|
-
|
|
Jul 25
2022
|
Scott J. Leffler Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
5,042,016
+49.95%
|
-
|
|
Jul 22
2022
|
Carladenise Armbrister Edwards Director |
BUY
Grant, award, or other acquisition
|
Direct |
8,805
+50.0%
|
-
|
|
Jul 18
2022
|
Brady Patrick Priest CEO of Home Care |
BUY
Grant, award, or other acquisition
|
Direct |
1,694,915
+50.0%
|
-
|
|
May 09
2022
|
Aric R Sharp CEO of Value Based Care |
BUY
Grant, award, or other acquisition
|
Direct |
370,967
+50.0%
|
-
|
|
Mar 14
2022
|
Prabhdeep Singh Chief Growth Officer |
BUY
Grant, award, or other acquisition
|
Direct |
255,474
+32.97%
|
-
|
|
Mar 14
2022
|
Jamie L. Reynoso CEO, Medicare Advantage |
BUY
Grant, award, or other acquisition
|
Direct |
510,948
+40.6%
|
-
|
|
Mar 14
2022
|
Joseph Richards Martin General Counsel |
BUY
Grant, award, or other acquisition
|
Direct |
3,100,775
+50.0%
|
-
|
|
Mar 11
2022
|
Lee Shapiro Director |
BUY
Open market or private purchase
|
Direct |
80,000
+42.76%
|
$240,000
$3.1 P/Share
|
|
Mar 03
2022
|
Chelsea Clinton Director |
BUY
Open market or private purchase
|
Direct |
100,000
+50.0%
|
$200,000
$2.53 P/Share
|
|
Jan 31
2022
|
Jamie L. Reynoso CEO, Medicare Advantage |
BUY
Grant, award, or other acquisition
|
Direct |
15,771
+6.25%
|
-
|
|
Jan 07
2022
|
Jamie L. Reynoso CEO, Medicare Advantage |
SELL
Payment of exercise price or tax liability
|
Direct |
15,830
-1.09%
|
$47,490
$3.16 P/Share
|
|
Jan 07
2022
|
Lee Shapiro Director |
BUY
Exercise of conversion of derivative security
|
Direct |
27,100
+50.0%
|
-
|
|
Jan 07
2022
|
William G Robinson Jr Director |
BUY
Exercise of conversion of derivative security
|
Direct |
27,100
+50.0%
|
-
|
|
Jan 07
2022
|
Vivek Garipalli Director |
SELL
Payment of exercise price or tax liability
|
Direct |
1,664,825
-49.8%
|
$4,994,475
$3.16 P/Share
|
|
Jan 07
2022
|
Vivek Garipalli Director |
BUY
Exercise of conversion of derivative security
|
Direct |
3,342,698
+50.0%
|
-
|
|
Nov 22
2021
|
Chamath Palihapitiya > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
1,739,130
+50.0%
|
$8,695,650
$5.75 P/Share
|
|
Aug 20
2021
|
Chamath Palihapitiya > 10% Shareholder |
SELL
Other acquisition or disposition
|
Indirect |
750,000
-2.57%
|
-
|
|
Aug 16
2021
|
Chamath Palihapitiya > 10% Shareholder |
BUY
Exercise of conversion of derivative security
|
Indirect |
2,245,980
+7.15%
|
-
|
|
Aug 09
2021
|
Joseph F. Wagner Chief Financial Officer |
BUY
Conversion of derivative security
|
Direct |
25,000
+50.0%
|
-
|
|
Jul 16
2021
|
Jamie L. Reynoso CEO, Medicare Advantage |
BUY
Grant, award, or other acquisition
|
Direct |
220,820
+50.0%
|
-
|
|
Jul 08
2021
|
Prabhdeep Singh Chief Growth Officer |
BUY
Grant, award, or other acquisition
|
Direct |
263,991
+33.33%
|
-
|
|
Jul 07
2021
|
Chamath Palihapitiya > 10% Shareholder |
SELL
Other acquisition or disposition
|
Indirect |
20,500,000
-100.0%
|
-
|
|
Jan 07
2021
|
Jacqueline D Reses |
BUY
Grant, award, or other acquisition
|
Direct |
200,000
+40.0%
|
$2,000,000
$10.0 P/Share
|